ClinicalTrials.govpublic full text
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
breast neoplasms, breast diseases, palbociclib, trastuzumab, pertuzumab, hormone antagonists, anastrozole, arimidex, ibrance, perjeta, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865728
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.